| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514534000 |
Z or Y radical contains a nitrogen atom
| 84 |
| 514533000 |
Compound contains two or more C(=O)O groups indirectly bonded together by only conalent bonds
| 62 |
| 514543000 |
Z forms a phenoxy alkyl or phenoxy alkenyl radical
| 24 |
| 514544000 |
C(=O)O attached directly through the carbon to a benzene ring
| 22 |
| 514545000 |
Ketone in Z radical | 5 |
| 20080306151 | DEUTERIUM-ENRICHED FENOFIBRATE - The present application describes deuterium-enriched fenofibrate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 12-11-2008 |
| 20090170939 | Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy - This invention relates to the use of fenofibrate or a derivative thereof for the manufacture of a medicament for the prevention and/or treatment of retinopathy. | 07-02-2009 |
| 20110263705 | TRANSDERMAL DELIVERY OF KETOPROFEN POLAR DERIVATES - A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen. | 10-27-2011 |
| 20100081715 | Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative Thereof - A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof a other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically ceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described. | 04-01-2010 |
| 20100144874 | Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides - The present invention relates to the combined use of a PPARα agonist and metformin for decreasing serum triglycerides. | 06-10-2010 |
| Entries |
| Document | Title | Date |
|---|
| 20100152290 | Benzo Lipoxin Analogues - Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation. | 06-17-2010 |
| 20100076078 | INSECTICIDAL COMPOUNDS - Novel compounds of formula (I): wherein A | 03-25-2010 |
| 20080280978 | Insect Repellent Compositions - An insect repellent composition containing 3,8-p-menthane-diol and benzylbenzoate as active compounds is described. Typically, the active compounds are each present in the composition in an amount which is less than an amount of the compound required to be effective as an insect repellent by itself. The composition may additionally include one or more additional active compounds selected from the group consisting of 2-butyl-2-ethyl-1,3-propanediol, 2-ethyl-1,3hexanediol and 5-N-butylacetanilide. One or more promoters, carriers, diluents, dispersants, solvents, emollients, emulsifiers, colouring agents, fragrances or thickening agents may also be included in the composition. | 11-13-2008 |
| 20080207751 | Sulindac Derivatives for Treatment of Cancer - The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) derivatives of sulindac, for the treatment/prevention, alone or in combination, of cancer. | 08-28-2008 |
| 20100137433 | Production of Rosmarinic Acid from Spearmint and uses Thereof - The present invention provides plants and plant tissues of spearmint ( | 06-03-2010 |
| 20080319067 | 2-Hydroxy-6-phenylphenanthridines as PDE-4 inhibitors - The compounds of formula I | 12-25-2008 |
| 20090221701 | Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure - The use of fibrates, particularly clofibrate, is described for the preparation of a medicament useful in the treatment of congestive heart failure. | 09-03-2009 |
| 20100160432 | Curative drug for neurodegenerative diseases - A compound is prepared based on Formula 1: | 06-24-2010 |
| 20120142772 | Benzo Lipoxin Analogues - Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation. | 06-07-2012 |
| 20100331409 | Use of Methyl Cinnamate in the Inhibition of Candida Albicans Biofilms - The invention provides a method of inhibiting biofilm formation or development of | 12-30-2010 |
| 20090076142 | USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS - The invention provides methods of synthesizing the purified enantiomers of oleocanthal. The invention further provides methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools for mammalian irritation receptor genes, gene products, alleles, splice variants, alternate transcripts and the like. | 03-19-2009 |
| 20080249167 | Compounds and methods for delivery of prostacyclin analogs - This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have the following formula: | 10-09-2008 |
| 20100004331 | ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD | 01-07-2010 |
| 20100261789 | Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes - The present invention relates to butenoic acid derivatives of the formula I: | 10-14-2010 |
| 20100160433 | TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISORDERS - A method of treating a neurodegenerative or cardiovascular disorder with a compound of the following formula: | 06-24-2010 |
| 20110015265 | METHOD FOR CONTROLLING DISEASES ON TURFGRASS - The present invention provides a method for controlling diseases on turfgrass which comprises applying to turfgrass that has been cut back an effective amount of a compound of formula ( | 01-20-2011 |
| 20100093853 | USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA - The present invention provides the use of (−)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes and hyperlipidemia. | 04-15-2010 |
| 20110275712 | Oil In Water Emulsion Cosmetic Composition For Skin - An oil in water emulsion cosmetic composition for skin, in which vitamin A and its derivatives are stably incorporated and which has superior feeling in use (skin familiarity or feeling of skin absorption, feeling of efficacy after application) and base composition stability (emulsion stability) with the passage of time. The oil in water emulsion cosmetic composition for skin comprises, relative to the total amount of the cosmetic composition, (a) from 0.01 to 4% by mass of vitamin A and its derivative, (b) from 0.6 to 4% by mass of a nonionic surfactant comprising three of (b-1) sorbitan tristearate, (b-2) polyethylene glycol stearate with from 20 to 120 mols of polyethylene glycol added thereto, (b-3) glyceryl stearate having an HLB of from 5 to 8, and (c) from 1 to 10% by mass of a higher alcohol having from 14 to 24 carbon atoms, wherein the blend ratio (by mass) of component (b-1) to component (b) is from 0.1 to 0.8. | 11-10-2011 |
| 20080234370 | Calcilytic Compounds - Novel calcilytic compounds and methods of using them are provided. | 09-25-2008 |
| 20090062384 | NOVEL ABIETANE DITERPENOID COMPOUND, AND COMPOSITION COMPRISING EXTRACT OF TORREYA NUCIFERA, OR ABIETANE DITERPENOID COMPOUNDS OR TERPENOID COMPOUNDS ISOLATED FROM THEM FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE - The present invention relates to a composition for the prevention and the treatment of cardiovascular disease containing extracts of | 03-05-2009 |
